(Q34547828)

2 August 2017

1 reference

title

Effect of antimicrobial agents on the ecological balance of human microflora (English)

1 reference

2 August 2017

1 reference

A Sullivan

1

1 reference

2 August 2017

C Edlund

series ordinal

2

1 reference

2 August 2017

C E Nord

series ordinal

3

1 reference

2 August 2017

publication date

1 September 2001

1 reference

Lancet Infectious Diseases

2 August 2017

published in

1 reference

2 August 2017

volume

1

1 reference

2 August 2017

issue

2

1 reference

2 August 2017

page(s)

101-114

1 reference

maintained by WikiProject

2 August 2017

1 reference

Development and persistence of multi-resistance to antibiotics in bacteria; an analysis and a new approach to this urgent problem

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900066-4

7 January 2021

Colonization resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900066-4

7 January 2021

Comparative effects of cefadroxil and phenoxymethylpenicillin on the normal oropharyngeal and intestinal microflora

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900066-4

7 January 2021

Influence of phenoxymethylpenicillin on the vaginal ecosystem

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900066-4

7 January 2021

Effect of lactic acid producing bacteria on the human intestinal microflora during ampicillin treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900066-4

7 January 2021

Swedish Study Group. A randomized multicenter trial to compare the influence of cefaclor and amoxycillin on the colonization resistance of the digestive tract in patients with lower respiratory tract infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900066-4

7 January 2021

Impact of cefpodoxime proxetil and amoxicillin on the normal oral and intestinal microflora.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900066-4

7 January 2021

Effect of loracarbef and amoxicillin on the oropharyngeal and intestinal microflora of patients with bronchitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900066-4

7 January 2021

The relationship between an increase in beta-lactamase activity after oral administration of three new cephalosporins and protection against intestinal ecological disturbances.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900066-4

7 January 2021

Effects of omeprazole and amoxycillin on the human oral and gastrointestinal microflora in patients with Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900066-4

7 January 2021

Changes in periurethral microflora after antimicrobial drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900066-4

7 January 2021

Ecological effects on the oro- and nasopharyngeal microflora in children after treatment of acute otitis media with cefuroxime axetil or amoxycillin-clavulanate as suspensions

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900066-4

7 January 2021

Effect of piperacillin/tazobactam treatment on human bowel microflora

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900066-4

7 January 2021

Effect of perorally administered pivmecillinam on the normal oropharyngeal, intestinal and skin microflora

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900066-4

7 January 2021

Antibiotics and Clostridium difficile

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900066-4

7 January 2021

Multiple dose pharmacokinetics, safety, and effects on faecal microflora, of cefepime in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900066-4

7 January 2021

Influence of cefpirome on pharyngeal and faecal flora after single and multiple intravenous administrations of cefpirome to healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900066-4

7 January 2021

The effect of ceftriaxone on the anaerobic bacterial flora and the bacterial enzymatic activity in the intestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900066-4

7 January 2021

Effect of intramuscular ceftriaxone on aerobic oral and faecal flora of 11 healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900066-4

7 January 2021

Effect of a Broad-Spectrum Cephalosporin on the Oral and Intestinal Microflora in Patients Undergoing Colorectal Surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900066-4

7 January 2021

Effect of step-down therapy of ceftriaxone plus loracarbef versus parenteral therapy of ceftriaxone on the intestinal microflora in patients with community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900066-4

7 January 2021

Effect of supplements with lactic acid bacteria and oligofructose on the intestinal microflora during administration of cefpodoxime proxetil

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900066-4

7 January 2021

Multiple-dose pharmacokinetics of cefprozil and its impact on intestinal flora of volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900066-4

7 January 2021

Effect of ceftibuten on the normal intestinal microflora.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900066-4

7 January 2021

Effect of vancomycin on intestinal flora of patients who previously received antimicrobial therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900066-4

7 January 2021

Effect of loracarbef on the normal oropharyngeal and intestinal microflora

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900066-4

7 January 2021

Effect of meropenem on the intestinal microflora

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900066-4

7 January 2021

Pharmacokinetics and safety of BO-2727, a new injectable 1-beta-methyl carbapenem antibiotic, and its effect on the faecal microflora in healthy male volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900066-4

7 January 2021

Impact of moxifloxacin versus clarithromycin on normal oropharyngeal microflora.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900066-4

7 January 2021

Comparative effects of clarithromycin and erythromycin on the normal intestinal microflora

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900066-4

7 January 2021

Comparative effects of moxifloxacin and clarithromycin on the normal intestinal microflora

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900066-4

7 January 2021

Pharmacokinetics and comparative effects of telithromycin (HMR 3647) and clarithromycin on the oropharyngeal and intestinal microflora

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900066-4

7 January 2021

Impact of dirithromycin on the normal oral and intestinal microflora

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900066-4

7 January 2021

Effects of roxithromycin on fecal bacteria in human volunteers and resistance to colonization in gnotobiotic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900066-4

7 January 2021

Impact on human intestinal microflora of an Enterococcus faecium probiotic and vancomycin

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900066-4

7 January 2021

Influence of oral glycopeptides on the fecal flora of human volunteers: selection of highly glycopeptide-resistant enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900066-4

7 January 2021

Comparative effects of omeprazole, amoxycillin plus metronidazole versus omeprazole, clarithromycin plus metronidazole on the oral, gastric and intestinal microflora in Helicobacter pylori-infected patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900066-4

7 January 2021

Effect of norfloxacin, trimethoprim-sulfamethoxazole and nitrofurantoin on fecal flora of women with recurrent urinary tract infections.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900066-4

7 January 2021

Norfloxacin binds to human fecal material

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900066-4

7 January 2021

Could bacterial vaginosis be due to the competitive suppression of lactobacilli by aerobic microorganisms?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900066-4

7 January 2021

Influence of low dose ciprofloxacin on microbial colonization of the digestive tract in healthy volunteers during normal and during impaired colonization resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900066-4

7 January 2021

Ecological effects of short-term ciprofloxacin treatment of travellers' diarrhoea

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900066-4

7 January 2021

Influence of intravenously administered ciprofloxacin on aerobic intestinal microflora and fecal drug levels when administered simultaneously with sucralfate

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900066-4

7 January 2021

Ecological disturbances in intestinal microflora caused by clinafloxacin, an extended-spectrum quinolone.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900066-4

7 January 2021

Ecological effect of gatifloxacin on the normal human intestinal microflora

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900066-4

7 January 2021

Effects of single oral doses of gemifloxacin (320 milligrams) versus trovafloxacin (200 milligrams) on fecal flora in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900066-4

7 January 2021

Impact of gemifloxacin on the normal human intestinal microflora

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900066-4

7 January 2021

Comparative effects of levofloxacin and ofloxacin on the normal oral and intestinal microflora

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900066-4

7 January 2021

Comparison of rufloxacin and norfloxacin effects on faecal flora

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900066-4

7 January 2021

Influence of pefloxacin on microbial colonization resistance in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900066-4

7 January 2021

The impact of rufloxacin given as prophylaxis to patients with cancer on their oral and faecal microflora

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900066-4

7 January 2021

Multiple-dose pharmacokinetics of sparfloxacin and its influence on fecal flora

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900066-4

7 January 2021

A double-blind, placebo-controlled, parallel group study of oral trovafloxacin on bowel microflora in healthy male volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900066-4

7 January 2021

10.1016/S1473-3099(01)00066-4

Identifiers

DOI

1 reference

2 August 2017

1 reference